<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//new-home-akn.urofrance.org/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/traitement/tumeur-metastatique/traitement-local-des-metastases/</loc>
		<lastmod>2021-06-29T10:28:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/traitement/tumeur-metastatique/place-de-la-nephrectomie-cytoreductrice/</loc>
		<lastmod>2021-06-29T10:12:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/traitement/</loc>
		<lastmod>2021-06-29T10:02:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/traitement/tumeur-localement-avancee/</loc>
		<lastmod>2021-06-29T09:56:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/traitement/tumeur-localisee/</loc>
		<lastmod>2021-06-29T09:50:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/demarche-diagnostique/</loc>
		<lastmod>2021-06-29T09:25:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/demarche-diagnostique/indication-de-la-consultation-oncogenetique/</loc>
		<lastmod>2021-06-29T09:24:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/demarche-diagnostique/place-de-lirm/</loc>
		<lastmod>2021-06-29T09:15:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/classifications/</loc>
		<lastmod>2021-06-29T08:44:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/classifications/classification-pronostique-de-heng-imdc-tumeurs-metastatiques/</loc>
		<lastmod>2021-06-29T08:29:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/classifications/classification-pronostique-du-mskcc-tumeurs-metastatiques/</loc>
		<lastmod>2021-06-29T08:24:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-des-cancers-urologiques/rein/classifications/classification-uiss-tumeurs-localisees/</loc>
		<lastmod>2021-06-29T08:14:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/risque-infectieux/</loc>
		<lastmod>2021-06-24T17:41:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/risque-infectieux/autres/</loc>
		<lastmod>2021-06-24T17:41:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/risque-infectieux/detersion/</loc>
		<lastmod>2021-06-24T17:38:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/risque-infectieux/antisepsie/</loc>
		<lastmod>2021-06-24T17:38:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/risque-infectieux/pilosites/</loc>
		<lastmod>2021-06-24T17:28:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/risque-infectieux/douche-preoperatoire/</loc>
		<lastmod>2021-06-24T17:23:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/antibioprophylaxie/</loc>
		<lastmod>2021-06-24T17:13:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/antibioprophylaxie/chirurgie-de-lappareil-genital-de-la-femme/</loc>
		<lastmod>2021-06-24T17:13:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/antibioprophylaxie/chirurgie-de-lappareil-genital-de-lhomme/</loc>
		<lastmod>2021-06-24T17:08:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/antibioprophylaxie/chirurgie-de-luretre/</loc>
		<lastmod>2021-06-24T17:03:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/antibioprophylaxie/chirurgie-de-la-vessie/</loc>
		<lastmod>2021-06-24T16:55:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/antibioprophylaxie/chirurgie-de-la-prostate/</loc>
		<lastmod>2021-06-24T16:16:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/mst/</loc>
		<lastmod>2021-06-24T15:25:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/mst/precautions-chez-la-femme-enceinte/</loc>
		<lastmod>2021-06-24T15:25:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/mst/donovanose/</loc>
		<lastmod>2021-06-24T15:21:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/mst/lymphogranulomatose-venerienne-maladie-de-nicolas-favre/</loc>
		<lastmod>2021-06-24T15:16:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/mst/chancre-mou-haemophilus-ducreyi/</loc>
		<lastmod>2021-06-24T15:13:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/mst/mycoplasma-genitalium/</loc>
		<lastmod>2021-06-24T14:47:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/mst/chlamydia-trachomatis/</loc>
		<lastmod>2021-06-24T14:42:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/pediatrie/traitement/infection-urinaire-febrile-du-nourrisson-et-du-jeune-enfant/</loc>
		<lastmod>2021-06-24T12:54:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/pediatrie/traitement/infection-urinaire-febrile-du-nourrisson-et-du-jeune-enfant/traitement-initial/</loc>
		<lastmod>2021-06-24T12:33:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/pediatrie/traitement/</loc>
		<lastmod>2021-06-24T12:19:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/pediatrie/traitement/cystite/</loc>
		<lastmod>2021-06-24T12:16:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/pediatrie/</loc>
		<lastmod>2021-06-24T11:16:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/grossesse/pyelonephrite/</loc>
		<lastmod>2021-06-24T11:03:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/grossesse/pyelonephrite/pyelonephrite-aigue-gravidique-grave/</loc>
		<lastmod>2021-06-24T11:03:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/grossesse/pyelonephrite/pyelonephrite-aigue-gravidique-sans-signes-de-gravite/</loc>
		<lastmod>2021-06-24T10:50:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/grossesse/</loc>
		<lastmod>2021-06-24T10:38:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/grossesse/cystite/</loc>
		<lastmod>2021-06-24T10:33:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iuas/</loc>
		<lastmod>2021-06-24T10:14:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iuas/traitement-documente/</loc>
		<lastmod>2021-06-24T10:09:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iuas/modalites-de-traitement/</loc>
		<lastmod>2021-06-24T09:53:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iuas/qui-traiter/</loc>
		<lastmod>2021-06-24T09:48:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iuas/criteres-microbiologiques/</loc>
		<lastmod>2021-06-24T09:41:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iuas/elements-diagnostiques/</loc>
		<lastmod>2021-06-24T09:39:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iu-communautaires/</loc>
		<lastmod>2021-06-23T09:52:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iu-communautaires/iu-masculine/</loc>
		<lastmod>2021-06-23T09:51:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iu-communautaires/pyelonephrite/adaptation-a-lantibiogramme/</loc>
		<lastmod>2021-06-23T09:18:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iu-communautaires/pyelonephrite/</loc>
		<lastmod>2021-06-23T08:57:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iu-communautaires/pyelonephrite/traitement-probabiliste-des-pyelonephrite/</loc>
		<lastmod>2021-06-23T08:45:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iu-communautaires/cystite/cystite-a-risque-de-complication/</loc>
		<lastmod>2021-06-23T08:23:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iu-communautaires/cystite/</loc>
		<lastmod>2021-06-23T08:19:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/recommandations-ciafu-urologie/iu-communautaires/cystite/cystite-simple/</loc>
		<lastmod>2021-06-22T14:04:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/afu/communications-afu/lettre-du-sncuf/</loc>
		<lastmod>2021-06-02T14:35:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/espace-personnel/mes-achats/</loc>
		<lastmod>2021-04-22T12:05:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/les-evenements-de-lafu/chirurgie-de-la-verge-et-de-luretre/</loc>
		<lastmod>2021-04-14T06:53:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/alf-one-alfuzosine-once-daily/</loc>
		<lastmod>2021-04-13T07:44:02+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/image2.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/image1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/altess/</loc>
		<lastmod>2021-04-13T07:44:02+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/image1_1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/image2_0.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/baseline-factors-as-predictors-of-clinical-progression-of-benign-prostatic-hyperplasia-in-men-treated-with-placebo/</loc>
		<lastmod>2021-04-13T07:44:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/relation-entre-les-troubles-urinaires-du-bas-appareil-tuba-et-les-dysfonctions-sexuelles-masculines-une-etude-observationnelle-internationale/</loc>
		<lastmod>2021-04-09T16:14:00+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/rosen-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/rosen-2.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/rosen-3.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/rosen-4.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/self-management-for-men-with-lower-urinary-tract-symptoms-randomized-controlled-trial/</loc>
		<lastmod>2021-04-09T16:14:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/tadalafil-en-prise-quotidienne/</loc>
		<lastmod>2021-04-09T16:14:00+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/tadalafil-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/the-effect-of-finasteride-in-men-with-benign-prostatic-hyperplasia-the-finasteride-study-group/</loc>
		<lastmod>2021-04-09T16:14:00+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/img-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/img-2.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/times-anticholinergiques-et-alphabloquants-pour-les-hommes-de-plus-de-40-ans-presentant-des-troubles-de-remplissage/</loc>
		<lastmod>2021-04-09T16:14:00+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/times-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/times-2.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/times-3.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/a-comparison-of-transurethral-surgery-with-watchful-waiting-for-moderate-symptoms-of-benign-prostatic-hyperplasia/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/bph-alf-group/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/bph-figure-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/bph-figure-2.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/combat-study-combination-of-avodart-and-tamsulosin-study/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/image1_3.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/image2_2.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/efficacite-de-leducation-des-patients-sur-les-troubles-mictionnels/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/efficacite-et-complications-de-lassociation-tamsulosin-oxybutynin-versus-tamsulosin-placebo-dans-le-traitement-des-troubles-urinaires-du-bas-appareil-de-lhomme-une-etude-randomise-en-double-av/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/diarmid-fig-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/efficacy-and-safety-of-the-coadministration-of-tadalafil-once-daily-with-finasteride-for-6-months-in-men-with-lower-urinary-tract-symptoms-and-prostatic-enlargement-secondary-to-benign-prostatic-hyper/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/image1_2.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/image2_1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/european-silodosin-group-study/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/european-silodosin-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/evaluation-de-la-securite-de-lassociation-tamsulosine-solifenacin-dans-le-traitement-des-troubles-urinaires-du-bas-appareil-de-lhomme-une-etude-controle-randomise-en-double-aveugle/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/figure-1-kaplan.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/figure-2-kaplan.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/goliath-study-12-months/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/principaux-resultats.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/goliath-study-group.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/holep/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/monotherapy-with-tadalafil-or-tamsulosin-similarly-improved-lower-urinary-tract-symptoms-suggestive-of-benign-prostatic-hyperplasia-in-an-international-randomised-parallel-placebo-controlled-clinic/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/monotherapy-figure-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/monotherapy-figure-2.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/mtops-study-medical-therapy-of-prostatic-symptoms/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/mtops.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/pcpt-prostate-cancer-prevention-trial/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/pcpt.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/pless-study-proscar-long-term-efficacy-and-safety-study/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/pless-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/reduce-reduction-by-dutasteride-of-prostate-cancer-events/</loc>
		<lastmod>2021-04-09T16:13:59+00:00</lastmod>
		<image:image>
			<image:loc>https://new-home-akn.urofrance.org/sites/default/files/reduce-1.png</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/questionnaires-devaluation/classification-de-clavien/</loc>
		<lastmod>2021-04-02T12:27:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/outils/questionnaires-devaluation/score-asa/</loc>
		<lastmod>2021-04-02T12:00:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/pratiques-professionnelles/evaluation-des-pratiques-professionnelles/presentation-generale/</loc>
		<lastmod>2021-04-02T07:01:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/histoire-de-lurologie-en-france/histoire-de-sfu-sfg/</loc>
		<lastmod>2021-03-31T20:51:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/histoire-de-lurologie-en-france/le-temps-des-precurseurs/</loc>
		<lastmod>2021-03-31T20:43:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/histoire-de-lurologie-en-france/</loc>
		<lastmod>2021-03-31T20:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/deposer-une-annonce/</loc>
		<lastmod>2021-03-20T21:59:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/afu/</loc>
		<lastmod>2021-03-17T06:38:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/histoire-de-lurologie-en-france/lurologie-francaise-au-19eme-siecle/</loc>
		<lastmod>2021-02-19T17:20:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/histoire-de-lurologie-en-france/la-france-et-la-pierre/</loc>
		<lastmod>2021-02-19T17:20:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/histoire-de-lurologie-en-france/le-vingtieme-siecle/</loc>
		<lastmod>2021-02-19T17:14:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/histoire-de-lurologie-en-france/felix-guyon-et-la-naissance-de-lurologie-moderne/</loc>
		<lastmod>2021-02-19T17:14:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/les-evenements-de-lafu/</loc>
		<lastmod>2021-02-12T10:36:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/essais-cliniques-en-onco-urologie/</loc>
		<lastmod>2021-02-12T09:40:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/bourses-de-lafu/</loc>
		<lastmod>2021-01-11T09:46:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/actualites/</loc>
		<lastmod>2020-12-21T08:42:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/travaux-des-comites/</loc>
		<lastmod>2020-12-10T09:15:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/fiches-infos-patients/</loc>
		<lastmod>2020-12-09T16:56:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/publications/recommandations/</loc>
		<lastmod>2020-12-09T14:43:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://new-home-akn.urofrance.org/lafu-academie/</loc>
		<lastmod>2020-12-03T14:47:03+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->